| http://www.w3.org/ns/prov#value | - In early stage estrogen receptor-positive (ER+) breast cancer, the 21-gene panel Oncotype DX assay and the Adjuvant!, based on age, tumor size and grade and other clinical variables, are widely used tools for patient prognosis and provide guidance in decision making.
|
